Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP986327.RAAIIdi7mjgwL2y9puBU6Y23q8PvtBtAWb7JZXArSEOzc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP986327.RAAIIdi7mjgwL2y9puBU6Y23q8PvtBtAWb7JZXArSEOzc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP986327.RAAIIdi7mjgwL2y9puBU6Y23q8PvtBtAWb7JZXArSEOzc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP986327.RAAIIdi7mjgwL2y9puBU6Y23q8PvtBtAWb7JZXArSEOzc130_provenance.
- NP986327.RAAIIdi7mjgwL2y9puBU6Y23q8PvtBtAWb7JZXArSEOzc130_assertion description "[Furthermore, the use of the FDA-approved drug trifluoperazine hydrochloride (TFP), which has been shown to inhibit FOXO1 nuclear export, restored sensitivity to AKT-driven erlotinib resistance through modulation of the KLF6/FOXO1 signaling cascade in both cell culture and xenograft models of lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP986327.RAAIIdi7mjgwL2y9puBU6Y23q8PvtBtAWb7JZXArSEOzc130_provenance.
- NP986327.RAAIIdi7mjgwL2y9puBU6Y23q8PvtBtAWb7JZXArSEOzc130_assertion evidence source_evidence_literature NP986327.RAAIIdi7mjgwL2y9puBU6Y23q8PvtBtAWb7JZXArSEOzc130_provenance.
- NP986327.RAAIIdi7mjgwL2y9puBU6Y23q8PvtBtAWb7JZXArSEOzc130_assertion SIO_000772 22653055 NP986327.RAAIIdi7mjgwL2y9puBU6Y23q8PvtBtAWb7JZXArSEOzc130_provenance.
- NP986327.RAAIIdi7mjgwL2y9puBU6Y23q8PvtBtAWb7JZXArSEOzc130_assertion wasDerivedFrom befree-2016 NP986327.RAAIIdi7mjgwL2y9puBU6Y23q8PvtBtAWb7JZXArSEOzc130_provenance.
- NP986327.RAAIIdi7mjgwL2y9puBU6Y23q8PvtBtAWb7JZXArSEOzc130_assertion wasGeneratedBy ECO_0000203 NP986327.RAAIIdi7mjgwL2y9puBU6Y23q8PvtBtAWb7JZXArSEOzc130_provenance.
- befree-2016 importedOn "2016-02-19" NP986327.RAAIIdi7mjgwL2y9puBU6Y23q8PvtBtAWb7JZXArSEOzc130_provenance.